O	0	9	Induction	Induction	NN	B-NP
O	10	12	of	of	IN	B-PP
O	13	21	p18INK4c	p18INK4c	NN	B-NP
O	22	25	and	and	CC	O
O	26	29	its	its	PRP$	B-NP
O	30	41	predominant	predominant	JJ	I-NP
O	42	53	association	association	NN	I-NP
O	54	58	with	with	IN	B-PP
O	59	63	CDK4	CDK4	NN	B-NP
O	64	67	and	and	CC	I-NP
O	68	72	CDK6	CDK6	NN	I-NP
O	73	79	during	during	IN	B-PP
O	80	88	myogenic	myogenic	JJ	B-NP
O	89	104	differentiation	differentiation	NN	I-NP
O	104	105	.	.	.	O

O	106	114	Terminal	Terminal	JJ	B-NP
B-Cell	115	119	cell	cell	NN	I-NP
O	120	135	differentiation	differentiation	NN	I-NP
O	136	144	involves	involve	VBZ	B-VP
O	145	154	permanent	permanent	JJ	B-NP
O	155	165	withdrawal	withdrawal	NN	I-NP
O	166	170	from	from	IN	B-PP
O	171	174	the	the	DT	B-NP
B-Cell	175	179	cell	cell	NN	I-NP
O	180	188	division	division	NN	I-NP
O	189	194	cycle	cycle	NN	I-NP
O	194	195	.	.	.	O

O	196	199	The	The	DT	B-NP
O	200	210	inhibitors	inhibitor	NNS	I-NP
O	211	213	of	of	IN	B-PP
O	214	220	cyclin	cyclin	NN	B-NP
O	220	221	-	-	HYPH	B-NP
O	221	230	dependent	dependent	JJ	I-NP
O	231	238	kinases	kinase	NNS	I-NP
O	239	240	(	(	(	O
O	240	244	CDKs	CDK	NNS	B-NP
O	244	245	)	)	)	O
O	246	249	are	be	VBP	B-VP
O	250	259	potential	potential	JJ	B-NP
O	260	269	molecules	molecule	NNS	I-NP
O	270	281	functioning	function	VBG	B-VP
O	282	284	to	to	TO	B-PP
O	285	291	couple	couple	NN	B-NP
B-Cell	292	296	cell	cell	NN	I-NP
O	297	302	cycle	cycle	NN	I-NP
O	303	309	arrest	arrest	NN	I-NP
O	310	313	and	and	CC	O
B-Cell	314	318	cell	cell	NN	B-NP
O	319	334	differentiation	differentiation	NN	I-NP
O	334	335	.	.	.	O

O	336	338	In	In	IN	B-PP
O	339	345	murine	murine	JJ	B-NP
B-Cell	346	351	C2C12	C2C12	NN	I-NP
I-Cell	352	360	myoblast	myoblast	NN	I-NP
I-Cell	361	366	cells	cell	NNS	I-NP
O	366	367	,	,	,	O
O	368	370	G1	G1	NN	B-NP
O	371	374	CDK	CDK	NN	I-NP
O	375	382	enzymes	enzyme	NNS	I-NP
O	383	384	(	(	(	O
O	384	388	CDK2	CDK2	NN	B-NP
O	388	389	,	,	,	O
O	390	394	CDK4	CDK4	NN	B-NP
O	394	395	,	,	,	O
O	396	399	and	and	CC	O
O	400	404	CDK6	CDK6	NN	B-NP
O	404	405	)	)	)	O
O	406	415	associate	associate	VBP	B-VP
O	416	420	with	with	IN	B-PP
O	421	425	four	four	CD	B-NP
O	426	429	CDK	CDK	NN	I-NP
O	430	440	inhibitors	inhibitor	NNS	I-NP
O	440	441	:	:	:	O
O	442	450	p18INK4c	p18INK4c	NN	B-NP
O	450	451	,	,	,	O
O	452	460	p19INK4d	p19INK4d	NN	B-NP
O	460	461	,	,	,	O
O	462	465	p21	p21	NN	B-NP
O	465	466	,	,	,	O
O	467	470	and	and	CC	O
O	471	478	p27Kip1	p27Kip1	NN	B-NP
O	478	479	.	.	.	O

O	480	486	During	During	IN	B-PP
O	487	494	induced	induce	VBN	B-NP
O	495	505	myogenesis	myogenesis	NN	I-NP
O	505	506	,	,	,	O
O	507	510	p21	p21	NN	B-NP
O	511	514	and	and	CC	O
O	515	518	its	its	PRP$	B-NP
O	519	529	associated	associate	VBN	I-NP
O	530	533	CDK	CDK	NN	I-NP
O	534	542	proteins	protein	NNS	I-NP
O	543	552	underwent	undergo	VBD	B-VP
O	553	555	an	an	DT	B-NP
O	556	563	initial	initial	JJ	I-NP
O	564	572	increase	increase	NN	I-NP
O	573	581	followed	follow	VBN	B-VP
O	582	584	by	by	IN	B-PP
O	585	586	a	a	DT	B-NP
O	587	595	decrease	decrease	NN	I-NP
O	596	598	as	as	IN	B-SBAR
B-Cell	599	604	cells	cell	NNS	B-NP
O	605	611	became	become	VBD	B-VP
O	612	622	terminally	terminally	RB	B-ADJP
O	623	637	differentiated	differentiate	VBN	I-ADJP
O	637	638	.	.	.	O

O	639	642	The	The	DT	B-NP
O	643	648	level	level	NN	I-NP
O	649	651	of	of	IN	B-PP
O	652	655	p27	p27	NN	B-NP
O	656	663	protein	protein	NN	I-NP
O	664	673	gradually	gradually	RB	B-ADVP
O	674	683	increased	increase	VBD	B-VP
O	683	684	,	,	,	O
O	685	688	but	but	CC	O
O	689	692	the	the	DT	B-NP
O	693	699	amount	amount	NN	I-NP
O	700	702	of	of	IN	B-PP
O	703	708	total	total	JJ	B-NP
O	709	719	associated	associate	VBN	I-NP
O	720	723	CDK	CDK	NN	I-NP
O	724	732	proteins	protein	NNS	I-NP
O	733	741	remained	remain	VBD	B-VP
O	742	751	unchanged	unchanged	JJ	B-ADJP
O	751	752	.	.	.	O

O	753	756	p19	p19	NN	B-NP
O	757	764	protein	protein	NN	I-NP
O	765	774	decreased	decrease	VBD	B-VP
O	775	784	gradually	gradually	RB	B-ADVP
O	785	791	during	during	IN	B-PP
O	792	807	differentiation	differentiation	NN	B-NP
O	807	808	,	,	,	O
O	809	811	as	as	IN	B-SBAR
O	812	815	did	do	VBD	O
O	816	819	its	its	PRP$	B-NP
O	820	830	associated	associate	VBN	I-NP
O	831	835	CDK4	CDK4	NN	I-NP
O	836	843	protein	protein	NN	I-NP
O	843	844	.	.	.	O

O	845	847	In	In	IN	B-PP
O	848	856	contrast	contrast	NN	B-NP
O	856	857	,	,	,	O
O	858	861	p18	p18	NN	B-NP
O	862	869	protein	protein	NN	I-NP
O	870	879	increased	increase	VBD	B-VP
O	880	882	50	50	CD	B-NP
O	882	883	-	-	HYPH	O
O	883	887	fold	fold	RB	B-ADVP
O	887	888	,	,	,	O
O	889	893	from	from	IN	B-PP
O	894	904	negligible	negligible	JJ	B-NP
O	905	911	levels	level	NNS	I-NP
O	912	914	in	in	IN	B-PP
O	915	928	proliferating	proliferate	VBG	B-VP
B-Cell	929	938	myoblasts	myoblast	NNS	B-NP
O	939	941	to	to	TO	B-PP
O	942	949	clearly	clearly	RB	B-NP
O	950	960	detectable	detectable	JJ	I-NP
O	961	967	levels	level	NNS	I-NP
O	968	974	within	within	IN	B-PP
O	975	976	8	8	CD	B-NP
O	976	977	-	-	HYPH	I-NP
O	977	979	12	12	CD	I-NP
O	980	981	h	h	NN	I-NP
O	982	984	of	of	IN	B-PP
O	985	993	myogenic	myogenic	JJ	B-NP
O	994	1003	induction	induction	NN	I-NP
O	1003	1004	.	.	.	O

O	1005	1009	This	This	DT	B-NP
O	1010	1017	initial	initial	JJ	I-NP
O	1018	1022	rise	rise	NN	I-NP
O	1023	1026	was	be	VBD	B-VP
O	1027	1035	followed	follow	VBN	I-VP
O	1036	1038	by	by	IN	B-PP
O	1039	1040	a	a	DT	B-NP
O	1041	1052	precipitous	precipitous	JJ	I-NP
O	1053	1061	increase	increase	NN	I-NP
O	1062	1069	between	between	IN	B-PP
O	1070	1072	12	12	CD	B-NP
O	1073	1076	and	and	CC	I-NP
O	1077	1079	24	24	CD	I-NP
O	1080	1081	h	h	NN	I-NP
O	1082	1095	postinduction	postinduction	NN	I-NP
O	1095	1096	,	,	,	O
O	1097	1101	with	with	IN	B-PP
O	1102	1105	p18	p18	NN	B-NP
O	1106	1113	protein	protein	NN	I-NP
O	1114	1121	finally	finally	RB	B-VP
O	1122	1134	accumulating	accumulate	VBG	I-VP
O	1135	1137	to	to	TO	B-PP
O	1138	1141	its	its	PRP$	B-NP
O	1142	1149	highest	high	JJS	I-NP
O	1150	1155	level	level	NN	I-NP
O	1156	1158	in	in	IN	B-PP
O	1159	1169	terminally	terminally	RB	B-NP
O	1170	1184	differentiated	differentiate	VBN	I-NP
B-Cell	1185	1190	cells	cell	NNS	I-NP
O	1190	1191	.	.	.	O

O	1192	1201	Induction	Induction	NN	B-NP
O	1202	1204	of	of	IN	B-PP
O	1205	1208	p18	p18	NN	B-NP
O	1209	1219	correlated	correlate	VBD	B-VP
O	1220	1224	with	with	IN	B-PP
O	1225	1234	increased	increase	VBN	B-NP
O	1235	1238	and	and	CC	I-NP
O	1239	1249	sequential	sequential	JJ	I-NP
O	1250	1257	complex	complex	NN	I-NP
O	1258	1267	formation	formation	NN	I-NP
O	1267	1268	-	-	HYPH	B-VP
O	1268	1269	-	-	SYM	B-NP
O	1269	1274	first	first	JJ	I-NP
O	1275	1285	increasing	increase	VBG	I-NP
O	1286	1297	association	association	NN	I-NP
O	1298	1302	with	with	IN	B-PP
O	1303	1307	CDK6	CDK6	NN	B-NP
O	1308	1311	and	and	CC	O
O	1312	1316	then	then	RB	B-ADVP
O	1317	1321	with	with	IN	B-PP
O	1322	1326	CDK4	CDK4	NN	B-NP
O	1327	1331	over	over	IN	B-PP
O	1332	1335	the	the	DT	B-NP
O	1336	1342	course	course	NN	I-NP
O	1343	1345	of	of	IN	B-PP
O	1346	1354	myogenic	myogenic	JJ	B-NP
O	1355	1370	differentiation	differentiation	NN	I-NP
O	1370	1371	.	.	.	O

O	1372	1375	All	All	DT	B-NP
O	1376	1378	of	of	IN	B-PP
O	1379	1382	the	the	DT	B-NP
O	1383	1387	CDK6	CDK6	NN	I-NP
O	1388	1391	and	and	CC	I-NP
O	1392	1396	half	half	NN	I-NP
O	1397	1399	of	of	IN	B-PP
O	1400	1403	the	the	DT	B-NP
O	1404	1408	CDK4	CDK4	NN	I-NP
O	1409	1413	were	be	VBD	B-VP
O	1414	1423	complexed	complexe	VBN	I-VP
O	1424	1428	with	with	IN	B-PP
O	1429	1432	p18	p18	NN	B-NP
O	1433	1435	in	in	IN	B-PP
O	1436	1446	terminally	terminally	RB	B-NP
O	1447	1461	differentiated	differentiate	VBN	I-NP
B-Cell	1462	1467	C2C12	C2C12	NN	I-NP
I-Cell	1468	1473	cells	cell	NNS	I-NP
O	1474	1476	as	as	RB	B-CONJP
O	1477	1481	well	well	RB	I-CONJP
O	1482	1484	as	as	IN	I-CONJP
O	1485	1487	in	in	IN	B-PP
O	1488	1493	adult	adult	JJ	B-NP
O	1494	1499	mouse	mouse	NN	I-NP
B-Tissue	1500	1506	muscle	muscle	NN	I-NP
I-Tissue	1507	1513	tissue	tissue	NN	I-NP
O	1513	1514	.	.	.	O

O	1515	1522	Finally	Finally	RB	B-ADVP
O	1522	1523	,	,	,	O
O	1524	1530	kinase	kinase	NN	B-NP
O	1531	1539	activity	activity	NN	I-NP
O	1540	1542	of	of	IN	B-PP
O	1543	1547	CDK2	CDK2	NN	B-NP
O	1548	1551	and	and	CC	I-NP
O	1552	1556	CDK4	CDK4	NN	I-NP
O	1557	1566	decreases	decrease	VBZ	B-VP
O	1567	1569	as	as	IN	B-PP
B-Cell	1570	1575	C2C12	C2C12	NN	B-NP
I-Cell	1576	1581	cells	cell	NNS	I-NP
O	1582	1595	differentiate	differentiate	VBP	B-VP
O	1595	1596	,	,	,	O
O	1597	1604	whereas	whereas	IN	O
O	1605	1608	the	the	DT	B-NP
O	1609	1613	CDK6	CDK6	NN	I-NP
O	1614	1620	kinase	kinase	NN	I-NP
O	1621	1629	activity	activity	NN	I-NP
O	1630	1632	is	be	VBZ	B-VP
O	1633	1636	low	low	JJ	B-ADJP
O	1637	1639	in	in	IN	B-PP
O	1640	1644	both	both	DT	B-NP
O	1645	1658	proliferating	proliferate	VBG	I-NP
B-Cell	1659	1668	myoblasts	myoblast	NNS	I-NP
O	1669	1672	and	and	CC	O
O	1673	1687	differentiated	differentiate	VBN	B-NP
B-Tissue	1688	1696	myotubes	myotube	NNS	I-NP
O	1696	1697	.	.	.	O

O	1698	1701	Our	Our	PRP$	B-NP
O	1702	1709	results	result	NNS	I-NP
O	1710	1718	indicate	indicate	VBP	B-VP
O	1719	1723	that	that	IN	B-SBAR
O	1724	1727	p18	p18	NN	B-NP
O	1728	1731	may	may	MD	B-VP
O	1732	1736	play	play	VB	I-VP
O	1737	1738	a	a	DT	B-NP
O	1739	1747	critical	critical	JJ	I-NP
O	1748	1752	role	role	NN	I-NP
O	1753	1755	in	in	IN	B-PP
O	1756	1763	causing	cause	VBG	B-VP
O	1764	1767	and	and	CC	O
O	1767	1768	/	/	SYM	B-NP
O	1768	1770	or	or	CC	O
O	1771	1782	maintaining	maintain	VBG	B-VP
O	1783	1792	permanent	permanent	JJ	B-NP
B-Cell	1793	1797	cell	cell	NN	I-NP
O	1798	1803	cycle	cycle	NN	I-NP
O	1804	1810	arrest	arrest	NN	I-NP
O	1811	1821	associated	associate	VBN	B-VP
O	1822	1826	with	with	IN	B-PP
O	1827	1833	mature	mature	JJ	B-NP
B-Tissue	1834	1840	muscle	muscle	NN	I-NP
O	1841	1850	formation	formation	NN	I-NP
O	1850	1851	.	.	.	O

